TY - JOUR
T1 - Cell trafficking of endothelial progenitor cells in tumor progression
AU - De La Puente, Pilar
AU - Muz, Barbara
AU - Azab, Feda
AU - Azab, Abdel Kareem
PY - 2013/7/1
Y1 - 2013/7/1
N2 - Blood vessel formation plays an essential role in many physiologic and pathologic processes, including normal tissue growth and healing, as well as tumor progression. Endothelial progenitor cells (EPC) are a subtype of stem cells with high proliferative potential that are capable of differentiating into mature endothelial cells, thus contributing to neovascularization in tumors. In response to tumor-secreted cytokines, EPCs mobilize from the bone marrow to the peripheral blood, home to the tumor site, and differentiate to mature endothelial cells and secrete proangiogenic factors to facilitate vascularization of tumors. In this review, we summarize the expression of surface markers, cytokines, receptors, adhesion molecules, proteases, and cell signaling mechanisms involved in the different steps (mobilization, homing, and differentiation) of EPC trafficking from the bone marrow to the tumor site. Understanding the biologic mechanisms of EPC cell trafficking opens a window for new therapeutic targets in cancer.
AB - Blood vessel formation plays an essential role in many physiologic and pathologic processes, including normal tissue growth and healing, as well as tumor progression. Endothelial progenitor cells (EPC) are a subtype of stem cells with high proliferative potential that are capable of differentiating into mature endothelial cells, thus contributing to neovascularization in tumors. In response to tumor-secreted cytokines, EPCs mobilize from the bone marrow to the peripheral blood, home to the tumor site, and differentiate to mature endothelial cells and secrete proangiogenic factors to facilitate vascularization of tumors. In this review, we summarize the expression of surface markers, cytokines, receptors, adhesion molecules, proteases, and cell signaling mechanisms involved in the different steps (mobilization, homing, and differentiation) of EPC trafficking from the bone marrow to the tumor site. Understanding the biologic mechanisms of EPC cell trafficking opens a window for new therapeutic targets in cancer.
UR - http://www.scopus.com/inward/record.url?scp=84879852167&partnerID=8YFLogxK
U2 - 10.1158/1078-0432.CCR-13-0462
DO - 10.1158/1078-0432.CCR-13-0462
M3 - Review article
C2 - 23665736
AN - SCOPUS:84879852167
SN - 1078-0432
VL - 19
SP - 3360
EP - 3368
JO - Clinical Cancer Research
JF - Clinical Cancer Research
IS - 13
ER -